Focada exclusivamente no desenvolvimento, 
                                        produção e promoção de produtos farmacêuticos especializados

Notice to the Market – Management change


Management change

Montevideo, Uruguay, June 29, 2018. GBT-Grupo Biotoscana (B3: GBIO33), a leading biopharmaceutical company in Latin America, announces to its shareholders and the market in general that Diego Sanguinetti will leave the company to join the Argentinean governmental with an official post at AFIP (Administración Federal de Ingresos Públicos) from today onwards.

Production, supply chain and logistics will remain with its respective responsible, as it was before his joining.

The management team thanks Mr. Sanguinetti on his short passage and contribution to the Company.

GBT – Grupo Biotoscana.

To access the PDF version, please click here.

Updated on 01/02/2019 at 04:31 pm